# Assessing Hydromorphone Sustained-Release Tablets in Elderly Cancer Pain Patients With Renal Insufficiency

> **NCT07421674** · — · NOT_YET_RECRUITING · sponsor: **Taian Cancer Hospital** · enrollment: 62 (estimated)

## Conditions studied

- Cancer Pain
- Renal Insufficiency Chronic
- Hydromorphone Use

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07421674
- **Lead sponsor:** Taian Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-10
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07421674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07421674, "Assessing Hydromorphone Sustained-Release Tablets in Elderly Cancer Pain Patients With Renal Insufficiency". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07421674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*